Parenteral Surgicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 0.50 M
as on 02-07-2024
- Company Age 18 Year,
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 12.79 Cr
as on 02-07-2024
- Revenue -99.98%
(FY 2021)
- Profit -101.54%
(FY 2021)
- Ebitda 45.75%
(FY 2021)
- Net Worth -0.30%
(FY 2021)
- Total Assets -97.35%
(FY 2021)
About Parenteral Surgicals
The Corporate was formerly known as Sanjiwani Medications Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹12.79 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pradeep Verma, Manoj Khandelwal, and Nitin Gujarati serve as directors at the Company.
- CIN/LLPIN
U24239MH2006PLC166415
- Company No.
166415
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2006
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Parenteral Surgicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Verma  | Director | 28-Oct-2010 | Current |
| Manoj Khandelwal | Director | 28-Oct-2010 | Current |
| Nitin Gujarati | Director | 28-Oct-2010 | Current |
Financial Performance and Corporate Structure Insights of Parenteral Surgicals.
Parenteral Surgicals Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 99.98% decrease. The company also saw a substantial fall in profitability, with a 101.54% decrease in profit. The company's net worth dipped by a decrease of 0.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parenteral Surgicals?
In 2021, Parenteral Surgicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Oct 2010 | ₹12.79 Cr | Satisfied |
How Many Employees Work at Parenteral Surgicals?
Unlock and access historical data on people associated with Parenteral Surgicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parenteral Surgicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parenteral Surgicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
